EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipid nanoparticle‐mediated RNA delivery for immune cell modulation

Emily H Kim, Sridatta V Teerdhala, Marshall S Padilla iD, Ryann A Joseph, Jacqueline J Li iD, Rebecca M Haley, Michael J Mitchell

European Journal of Immunology · 2024-12 · 54 (12)

DOI: 10.1002/eji.202451008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 16.09.2024. Verfasst von Emily H Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Nanoparticles, SARS-CoV-2, COVID-19, Immunotherapy. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSF CAREER Award, American Cancer Society, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) have emerged as the preeminent nonviral drug delivery vehicles for nucleic acid therapeutics, as exemplified by their usage in the mRNA COVID‐19 vaccines. As a safe and highly modular delivery platform, LNPs are attractive for a wide range of applications. In addition to vaccines, LNPs are being utilized as platforms for other immunoengineering efforts, especially as cancer immunotherapies by modulating immune cells and their functionality via nucleic acid delivery. In this review, we focus on the methods and applications of LNP‐based immunotherapy in five cell types: T cells, NK cells, macrophages, stem cells, and dendritic cells. Each of these cell types has wide‐reaching applications in immunotherapy but comes with unique challenges and delivery barriers. By combining knowledge of immunology and nanotechnology, LNPs can be developed for improved immune cell targeting and transfection, ultimately working toward novel clinical therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesSARS-CoV-2COVID-19ImmunotherapyHumansLipidsCOVID-19 VaccinesAnimalsDendritic CellsT-LymphocytesLiposomesKiller Cells, Natural

Stichwörter der Autor:innen

Dendritic cellsLipid nanoparticlesMacrophagesNK cellsT cells

Substanzen

LipidsCOVID-19 VaccinesLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Marshall S Padilla, Jacqueline J Li

Förderung

  • NSF CAREER Award
  • American Cancer Society
  • NIDCR NIH HHS
  • National Science Foundation Graduate Research Fellowship Program (NSF-GRFP)
  • NCATS NIH HHS
  • National Institute of Dental & Craniofacial Research (NIDCR) of the National Institutes of Health (NIH)

Zitieren

APA

Kim, E. H., Teerdhala, S. V., Padilla, M. S., Joseph, R. A., Li, J. J., Haley, R. M., & Mitchell, M. J. (2024). Lipid nanoparticle‐mediated RNA delivery for immune cell modulation. European Journal of Immunology, 54(12). https://doi.org/10.1002/eji.202451008

Vancouver

Kim EH, Teerdhala SV, Padilla MS, Joseph RA, Li JJ, Haley RM, et al. Lipid nanoparticle‐mediated RNA delivery for immune cell modulation. European Journal of Immunology. 2024;54(12). doi:10.1002/eji.202451008

BibTeX
@article{Kim2024,
  author = {Kim, Emily H and Teerdhala, Sridatta V and Padilla, Marshall S and Joseph, Ryann A and Li, Jacqueline J and Haley, Rebecca M and Mitchell, Michael J},
  title = {Lipid nanoparticle‐mediated RNA delivery for immune cell modulation},
  journal = {European Journal of Immunology},
  year = {2024},
  volume = {54},
  number = {12},
  doi = {10.1002/eji.202451008}
}
Kostenlos starten →